Re: Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated with New Cancer Medicines
- PMID: 29539893
- DOI: 10.1016/j.juro.2017.02.055
Re: Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated with New Cancer Medicines
Comment on
-
Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines.JAMA Oncol. 2017 Mar 1;3(3):382-390. doi: 10.1001/jamaoncol.2016.4166. JAMA Oncol. 2017. PMID: 28033447
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources